SCHEMBL3294497

SCHEMBL3294497

COc1ccc(C)cc1[SiH](O[SiH](c1ccccc1)c1cc(C)ccc1OC)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.47
ALDH1A1 P00352 3/20 0.43
CYP3A4 P08684 2/20 0.43
MAPT P10636 10/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
NQO2 P16083 1/20 0.39
L3MBTL1 Q9Y468 8/20 0.39
RAB9A P51151 5/20 0.39
NPC1 O15118 4/20 0.39
HPGD P15428 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
LMNA P02545 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
GAA P10253 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3295990 0.88 ACHE (0.46) ACHEALDH1A1CYP3A4MAPTMEN1
SCHEMBL3303357 0.85 ACHE (0.58) ACHEALDH1A1CYP3A4MAPTMEN1
SCHEMBL3296208 0.83 CA12 (0.47) ALDH1A1MAPTMEN1KMT2ANQO2
SCHEMBL3296357 0.82 CA1 (0.46) ALDH1A1MAPTKMT2ANQO2L3MBTL1
SCHEMBL3297848 0.76 NQO2 (0.43) ALDH1A1MAPTMEN1KMT2ANQO2
SCHEMBL3296746 0.76 CA1 (0.40) ALDH1A1CYP3A4MAPTMEN1KMT2A
SCHEMBL3301611 0.75 CYP1A1 (0.44) ACHEALDH1A1MEN1KMT2ANQO2
SCHEMBL3297833 0.75 CYP1A2 (0.47) ALDH1A1CYP3A4MAPTMEN1KMT2A
SCHEMBL3294404 0.73 ACHE (0.46) ACHEALDH1A1MEN1KMT2ANQO2
SCHEMBL3298764 0.72 MAPT (0.37) MAPTMEN1KMT2ANQO2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 ACHE 3477/4885ALDH1A1 1865/4885CYP3A4 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.